Sorbent Therapeutics

About:

Sorbent Therapeutics develops fluid-retaining polymers for kidney disease therapeutics.

Twitter/X: sorbent

Top Investors: ARCH Venture Partners, Novartis Venture Fund, Sofinnova Investments, CMEA Capital, AgeChem Venture Fund

Description:

Sorbent Therapeutics, Inc. develops treatment for end stage renal disease patients undergoing dialysis. The company develops fluid retaining polymers for therapeutic uses, such as treatment of kidney diseases. Sorbent Therapeutics, Inc. was founded in 2005 and is based in Vernon Hills, Illinois.

Total Funding Amount:

$110M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Sunnyvale, California, United States

Founded Date:

2005-01-01

Contact Email:

info(AT)sorbent.com

Founders:

William R. Rajski

Number of Employees:

11-50

Last Funding Date:

2014-05-15

IPO Status:

Private

Industries: